跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial - TGA Drug Approval Details
Approvals
/
TGA
/
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial
Approved
STANDARD
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial
Servier Laboratories (Aust) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
32cf75fbe1c11441
Company
Servier Laboratories (Aust) Pty Ltd
Type
Standard
Approval Details
Approval Id
32cf75fbe1c11441
Product Name
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial
Artg Id
303807
Artg Name
ONCASPAR pegaspargase 3750 units/5mL powder for solution injection/infusion vial
Sponsor
Servier Laboratories (Aust) Pty Ltd
Company Detail Path
/organization/servier-laboratories-aust-pty-ltd
Artg Date
2019-03-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/9411e62a0a12d22fa7fa94663e981749.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/ed57fa2836a19b69e93803da12374527.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
32cf75fbe1c11441
Type
Standard
Back to TGA Approvals